RAMM Pharma Corp Price Prediction
RAMMFDelisted Stock | USD 0.06 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using RAMM Pharma hype-based prediction, you can estimate the value of RAMM Pharma Corp from the perspective of RAMM Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in RAMM Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying RAMM because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
RAMM Pharma after-hype prediction price | USD 0.055 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
RAMM |
RAMM Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of RAMM Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in RAMM Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of RAMM Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
RAMM Pharma Estimiated After-Hype Price Volatility
In the context of predicting RAMM Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on RAMM Pharma's historical news coverage. RAMM Pharma's after-hype downside and upside margins for the prediction period are 0.05 and 0.06, respectively. We have considered RAMM Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
RAMM Pharma is very steady at this time. Analysis and calculation of next after-hype price of RAMM Pharma Corp is based on 3 months time horizon.
RAMM Pharma Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as RAMM Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading RAMM Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with RAMM Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.06 | 0.06 | 0.00 |
|
RAMM Pharma Hype Timeline
RAMM Pharma Corp is at this time traded for 0.06. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. RAMM is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on RAMM Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.06. About 35.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. RAMM Pharma Corp recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. Assuming the 90 days horizon the next expected press release will be within a week. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.RAMM Pharma Related Hype Analysis
Having access to credible news sources related to RAMM Pharma's direct competition is more important than ever and may enhance your ability to predict RAMM Pharma's future price movements. Getting to know how RAMM Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how RAMM Pharma may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
CVGRF | City View Green | 0.00 | 0 per month | 0.00 | 0.08 | 0.00 | 0.00 | 95.65 | |
SPBBF | Speakeasy Cannabis Club | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PHCG | Pure Harvest Cannabis | 0.00 | 0 per month | 0.00 | 0.11 | 100.00 | (50.00) | 150.00 | |
RVVQF | Ravenquest Biomed | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
BHHKF | Benchmark Botanics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
RAMM Pharma Additional Predictive Modules
Most predictive techniques to examine RAMM price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for RAMM using various technical indicators. When you analyze RAMM charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About RAMM Pharma Predictive Indicators
The successful prediction of RAMM Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as RAMM Pharma Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of RAMM Pharma based on analysis of RAMM Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to RAMM Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to RAMM Pharma's related companies.
Story Coverage note for RAMM Pharma
The number of cover stories for RAMM Pharma depends on current market conditions and RAMM Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that RAMM Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about RAMM Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
RAMM Pharma Short Properties
RAMM Pharma's future price predictability will typically decrease when RAMM Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of RAMM Pharma Corp often depends not only on the future outlook of the potential RAMM Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. RAMM Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 123.4 M | |
Shares Float | 89.2 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |